MOTS-c
From £20
In stock, ships today
In this bundle 2 items
£38
£43
Save £5 (12%) against buying each vial separately
- Sold out.
- Order within 12h 10m for dispatch today, estimated delivery Thu 12 Nov
- Free UK delivery over £100
- Discreet, plain unbranded packaging
Third-party lab reports
One for each compound. Every vial is sealed separately and nothing is mixed.
- CJC-1295 No DAC 5mg Batch CJN5.121, 99% purity View report
- Ipamorelin 5mg Batch IPA5.265, 99% purity View report
Pay by bank
About GHRH-GHRP Research Bundle
This research bundle pairs the GHRH analogue CJC-1295 (No DAC / Mod GRF 1-29) with the selective GHRP-class agonist Ipamorelin. The combination represents a dual-pathway secretagogue model used to investigate GHRH-receptor and GHS-R1a signalling concurrently in pituitary cell systems.
Primary areas of investigation
- GHRH receptor signalling research
- GHS-R1a receptor binding studies
- Pituitary somatotroph cell models
- cAMP / IP3 dual-pathway research
- Secretagogue interaction investigation
- Endocrine signalling cascade studies
Mechanism
The bundle brings together two convergent research pathways. CJC-1295 (No DAC) acts as a GHRH receptor agonist driving cAMP-mediated somatotroph signalling. Ipamorelin acts as a selective GHS-R1a agonist via phospholipase C / IP3 signalling. Investigation focuses on the interaction between GHRH and ghrelin-receptor pathways on growth hormone vesicle release dynamics in preclinical models.
Delivery and returns
Shipped in plain, unbranded packaging from our United Kingdom warehouse. Damaged on arrival? Tell us within 48 hours and we’ll put it right. Shipping and returns
For laboratory research use only. Not for human or veterinary use.
